Literature DB >> 15736519

International comparison of the definition and the practical application of health technology assessment.

Eva Draborg1, Dorte Gyrd-Hansen, Peter Bo Poulsen, Mogens Horder.   

Abstract

OBJECTIVES: Health Technology Assessment (HTA) is defined as a policy research approach that examines the short- and long-term social consequences of the application or use of technology. Internationally different institutions have translated this definition to local contexts. In Denmark, HTA is comprehensive with focus on four aspects of the problem in question (technology [clinical evidence], economy, patient, and organization). The objective of this study is to study how the application of HTA differs across leading countries and to study the extent to which Danish HTA reports differ from foreign HTAs.
METHODS: A sample of 433 HTA reports published in the period 1989--2002 by eleven leading institutions or agencies in Denmark and eight other countries were reviewed. We looked at the characteristics of the HTA with respect to focus on the four main aspects and the manner in which each aspect has been approached.
RESULTS: The study shows health technology procedures to be the most common type of health technology assessed in HTAs and literature review to be the most often used method of analysis. Policy recommendations are only present in approximately half of the HTA reports.
CONCLUSIONS: In the HTAs one generally sees a great focus on the clinical aspect of health technologies, leaving the economic, the patient-related, and the organizational aspect much more unanalyzed. The Danish HTAs generally have a wider scope than HTAs produced in other countries and tend to focus more frequently on patient-related and organizational dimensions.

Entities:  

Mesh:

Year:  2005        PMID: 15736519     DOI: 10.1017/s0266462305050117

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  17 in total

1.  Cardiac-CT and Cardiac-MR examinations cost analysis, based on data of four Italian Centers.

Authors:  Maurizio Centonze; Giuseppe Lorenzin; Andrea Francesconi; Filippo Cademartiri; Giulia Casagranda; Michele Fusaro; Guido Ligabue; Giovanna Zanetti; Demetrio Spanti; Francesco De Cobelli
Journal:  Radiol Med       Date:  2015-07-26       Impact factor: 3.469

2.  Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.

Authors:  B K Potter; D Avard; V Entwistle; C Kennedy; P Chakraborty; M McGuire; B J Wilson
Journal:  Public Health Genomics       Date:  2008-09-03       Impact factor: 2.000

3.  Health technology assessment and private payers' coverage of personalized medicine.

Authors:  Julia R Trosman; Stephanie L Van Bebber; Kathryn A Phillips
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

4.  HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2020-02

5.  Exploring qualitative research synthesis: the role of patients' perspectives in health policy design and decision making.

Authors:  Helle Ploug Hansen; Eva Draborg; Finn Børlum Kristensen
Journal:  Patient       Date:  2011       Impact factor: 3.883

6.  Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis.

Authors:  John F P Bridges
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

7.  Patient reported outcomes: looking beyond the label claim.

Authors:  Lynda C Doward; Ari Gnanasakthy; Mary G Baker
Journal:  Health Qual Life Outcomes       Date:  2010-08-20       Impact factor: 3.186

8.  Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation.

Authors:  Jennifer L Fackler; Amy L McGuire
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

9.  Ethical analysis to improve decision-making on health technologies.

Authors:  Samuli I Saarni; Bjørn Hofmann; Kristian Lampe; Dagmar Lühmann; Marjukka Mäkelä; Marcial Velasco-Garrido; Ilona Autti-Rämö
Journal:  Bull World Health Organ       Date:  2008-08       Impact factor: 9.408

10.  Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond.

Authors:  Mike Baldwin; Andrew Spong; Lynda Doward; Ari Gnanasakthy
Journal:  Patient       Date:  2011       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.